Account
Inquiry
Tirzepatide (LY3298176) represents a significant advancement in peptide-based therapeutics, functioning as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative compound demonstrates superior efficacy in glucose control and weight management compared to traditional GLP-1 receptor agonists.
Our pharmaceutical-grade Tirzepatide is supplied as a white lyophilized powder with purity exceeding 99%, making it ideal for research applications. The compound's unique dual mechanism of action offers researchers valuable insights into metabolic regulation and potential therapeutic applications.
When you buy Tirzepatide from our facility, you receive a product that has undergone rigorous quality control testing, including HPLC analysis to verify purity and consistency. The peptide is packaged under controlled conditions to ensure stability and longevity.
For research institutions and pharmaceutical developers seeking bulk quantities, we offer competitive pricing on custom orders of Tirzepatide with flexible packaging options to meet specific project requirements. Our production capabilities allow for scale-up to meet large-scale research needs.
As with all our peptide products, this material is supplied for research use only and not intended for human consumption. Proper handling procedures should be followed when working with lyophilized peptides in laboratory settings.
